Skip to main content
# العنوان سنة البحث
341 Enhanced Delivery of Baclofen Through Blood-Brain Barrier Using Poly(butyl cyanoacrylate) Nanoparticles Coated with Polysorbate-80 as a Carrying Vector. 2009
342 The influence of experimental schistosomiasis on the pharmacokinetics and pharmacodynamics of phenobarbital and diphenylhydantoin in mice 2009
343 Comparative study for brain delivery of tacrine using polysorbate 80 – coated poly(butylcyanoacrylate) and pegylated-poly(butylcyanoacrylate) nanoparticles. 2009
344 Enhanced delivery of baclofen through blood brain barrier using poly (butyl cyanoacrylate) nanoparticles coated with polysorbate-80. 2009
345 Pegylated polybutylcyanoacrylate nanoparticles as a vector for enhancement of baclofen delivery through blood-brain barrier. 2008
346 Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach.
2008
347 5-(4-Chlorophenyl)-5,6-dihydro-1,3-oxazepin-7(4H)-one derivatives as lipophilic cyclic analogues of baclofen: Design, synthesis, and neuropharmacological evaluation. 2008
348 Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach.
2008
349 The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. 2008
350 5-(4-Chlorophenyl)-5,6-dihydro-1,3-oxazepin-7(4H)-one derivatives as lipophilic cyclic analogues of baclofen: Design, synthesis, and neuropharmacological evaluation. 2008